We are thrilled to announce our partnership with Breast Cancer Aotearoa Coalition (BCAC) Inc. We will donate $20,000 to BCAC over the next year as the organisation launches a special focus on women with secondary breast cancer. The aim is to better support the hundreds of New Zealanders currently living with secondary breast cancer. This includes greater access to treatments and medicines for those with secondary breast cancer to ensure that these women have a better quality of life and potentially longer lives too.
Karen was passionate about making sure those with secondary breast cancer were not forgotten about and we will continue to make sure that work and commitment continues.
Read the full article here
We raised $35K in one gorgeously long afternoon packed with food, wine and lots of generous hearts and wallets!!! $35K!!!!
We are SO grateful and blown away by everyone’s support – thank you so much to those that came along. The auction went so well and the raffle tickets were snapped up. The $10 lucky dip pinata’s were also gone in a heartbeat! The Spanish music, the amazing flowers, the yum food that kept coming and coming…..it truly was a fantastic afternoon.
The auction items included 4 pieces of beautiful art – generously given to us by Exhibitions Gallery in Brandon St, Wellington. One of our most sought after pieces went for $5000!!! With the others going between an impressive $1200 to $2000! We had an unbelievable $3000 Whitebait voucher given to us by Armstrong Prestige to be auctioned, so was a “Night at the Footy” – 4x tickets at ABs vs Wales in June and dinner at Ombra beforehand. We also had 2 night’s accommodation at The Tongariro Lodge in Turangi kindly donated by the fabulous team up there. And because things were going so well we threw into the auction mix a night up to Auckland, flights for 2 on Air NZ and a night at Rydges Hotel, a $500 voucher at Harbourside Restaurant and lunch the next day at Brew on Quay. Phew!!!!!
PLUS!!!! We had $20 raffle items including –
- Whiskey galore! Gallon of Jamiesons whiskey and 2x other bottles to go with it
- A bouquet of gorgeous flowers from Scent Floral Bouquet once a month for a year PLUS a sterling silver cross necklace by Guthrie and Steel with velvet bag which retails at $700
- The White Swan in Greytown – one night in deluxe suite, French bubbles on arrival and 3 course dinner for 2
Thank you so much to everyone that donated items!!!!
All of our photos are on our Facebook page but here are a few sneaky pics to get you wanting to see more! One thing you can’t see is all the love coming our way in the room – it was in abundance!
We have an exciting announcement soon to come about what that money is going to contribute to……So stay tuned!!!!
BIG NEWS from us!!!
The Karen Louisa Foundation has committed $47K to support Dr. Parry Guilford & his team at the Centre of Translational Cancer research at Otago University in a seed project which researches circulating tumour DNA or ctDNA in the area of metastatic (advanced) breast cancer. There is strong evidence emerging internationally that ctDNA can be used as an early indicator of a patients response during and following cancer treatment and also if a patients cancer is recurring. Dr. Guilford videoed a short message and explanation of this in a little more detail for the launch party – if you have 3 minutes today check it out here . We can’t support these types of projects without your support so thank you from the bottom of our heart.
What is ctDNA?
Circulating tumour DNA (ctDNA) is DNA which has been spilt from cancer into the blood. There is strong evidence emerging internationally that the levels of ctDNA can be used as an early indicator of patient recurrence/response during and following cancer treatment such as chemotherapy and radiation. Traditional scanning techniques such as CT/PET scans are very useful, however changes in tumour sizes often need to be large to be identified. As a result patients often end up taking drugs which are providing little benefit and commonly, causing side effects which can considerable impact the quality of their life. For some, by the time either recurrence or growth is discovered, their cancer burden is too great and it is too late to try an alternative drug or their drug options are now limited.
Research shows that ctDNA could provide this sought-after earlier detection method. As it only takes a quick blood test it can be done as often as desired, leading to more intense patient monitoring and faster clinical response times. This allows the patient to quickly stop futile treatment and change their treatment plan, potentially giving them a longer life, all with a lower cost to the health care system.
There are many more extremely exciting things that ctDNA could be capable of such as potentially profiling a patient’s tumour, potentially allowing doctors to predict which drug would work better over others. But the first step in New Zealand is to develop the ctDNA technology & protocol for actual application on advanced breast cancer and test the methodology on breast cancer patients. Ultimately so that it this is standard clinical practice in New Zealand.
Pretty amazing huh?!